Dimension Therapeutics, Inc
DMTX
DMTX was delisted on the 6th of November, 2017.
55 hedge funds and large institutions have $90M invested in Dimension Therapeutics, Inc in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 9 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 12
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
2% more funds holding
Funds holding: 54 → 55 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
47% less capital invested
Capital invested by funds: $170M → $90M (-$80.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$932K |
| 2 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$670K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$297K |
| 4 |
Renaissance Technologies
New York
|
+$288K |
| 5 |
State Street
Boston,
Massachusetts
|
+$269K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$3.56M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$3.3M |
| 3 |
Asset Management One
Tokyo,
Japan
|
-$906K |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$320K |
| 5 |
SIM
Spark Investment Management
New York
|
-$302K |
DMTX Hedge Fund Activity: Q4 2016 in Review
55 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Dimension Therapeutics, Inc (DMTX) for Q4 2016, worth a combined $90M — down 47% from $170M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new DMTX positions and 9 closed out — a net gain of 1 holder — while 18 added to existing stakes and 12 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $932K. The largest seller was PFM Health Sciences, exiting entirely with an estimated $3.56M sold.
- 55 institutional investors held Dimension Therapeutics, Inc (DMTX) as of Q4 2016, up from 54 in Q3 2016.
- Funds reported $90M of Dimension Therapeutics, Inc stock for Q4 2016, down 47% quarter-over-quarter.
- 10 funds opened new Dimension Therapeutics, Inc positions in Q4 2016 and 9 closed out, a net change of +1 holder.
- The largest Dimension Therapeutics, Inc buyer in Q4 2016 was Millennium Management, an estimated $932K added.
- The largest Dimension Therapeutics, Inc seller in Q4 2016 was PFM Health Sciences, an estimated $3.56M sold.
Based on aggregated 13F filings for Q4 2016.